c-di-GMP; cyclic di-GMP; Cyclic-di-GMP; Cyclic diguanylic acid; cdiGMP; Cyclic diguanylate; 61093-23-0; 3',5'-Cyclic diguanylic acid; cGpGp; c-(Gpgp); Bis-(3',5')-cyclic diGMP; CHEMBL1231573; CHEBI:49537; cyclic di-3',5'-guanylate; 9,9'-[(2r,3r,3as,5s,7ar,9r,10r,10as,12s,14ar)-3,5,10,12-Tetrahydroxy-5,12-Dioxidooctahydro-2h,7h-Difuro[3,2-D:3',2'-J][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-Diyl]bis(2-Amino-1,9-Dihydro-6h-Purin-6-One); Cyclic-bis(3',5')diguanylic acid; Bis(3',5')-cyclic diguanylic acid; 2-amino-9-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one; (1S,6R,8R,9R,10S,15R,17R,18R)-8,17-bis(2-amino-6-hydroxypurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol; 5GP-5GP; Cyclicdiguanylate; C2E; 3',5'-Cyclic diGMP; 3',5'-cyclic di-GMP; cyclic dinucleotide di-GMP; SCHEMBL17974376; cyclic di-3',5'-guanylic acid; DTXSID801027528; cyclic-bis(3'->5') dimeric GMP; EX-A6951; BDBM50436163; ZINC72319544; CS-7977; BP-58810; c-di-GMP; Cyclic diguanosine monophosphate; HY-107780; Bis-(3'-5')-cyclic dimeric guanosine monophosphate; Q2649761; guanylyl-(3'->5')-3'-guanylic acid, cyclic 3'->5'''-nucleotide; (1S,6R,8R,9R,10S,15R,17R,18R)-8,17-bis(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-2,4,7,11,13,16-hexaoxa-3,12-diphosphatricyclo[13.3.0.0,octadecane-3,12-dione; 9,9'-[(2R,3R,3aS,7aR,9R,10R,10aS,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one)